OTRK vs. BRTX, MGRX, GBNHF, TNXP, MNPR, IMNN, BMRA, BNTC, SRNE, and CHEK
Should you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Greenbrook TMS (GBNHF), Tonix Pharmaceuticals (TNXP), Monopar Therapeutics (MNPR), Imunon (IMNN), Biomerica (BMRA), Benitec Biopharma (BNTC), Sorrento Therapeutics (SRNE), and Check-Cap (CHEK). These companies are all part of the "medical" sector.
BioRestorative Therapies (NASDAQ:BRTX) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.
Ontrak received 37 more outperform votes than BioRestorative Therapies when rated by MarketBeat users.
BioRestorative Therapies has a beta of 61.51, indicating that its stock price is 6,051% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.43, indicating that its stock price is 143% more volatile than the S&P 500.
Ontrak has a consensus target price of $4.00, suggesting a potential upside of 1,423.81%. Given BioRestorative Therapies' higher probable upside, analysts plainly believe Ontrak is more favorable than BioRestorative Therapies.
In the previous week, BioRestorative Therapies had 5 more articles in the media than Ontrak. MarketBeat recorded 15 mentions for BioRestorative Therapies and 10 mentions for Ontrak. Ontrak's average media sentiment score of 0.10 beat BioRestorative Therapies' score of -0.04 indicating that BioRestorative Therapies is being referred to more favorably in the media.
BioRestorative Therapies has higher earnings, but lower revenue than Ontrak. BioRestorative Therapies is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.
69.4% of BioRestorative Therapies shares are owned by institutional investors. Comparatively, 13.0% of Ontrak shares are owned by institutional investors. 21.6% of BioRestorative Therapies shares are owned by company insiders. Comparatively, 1.2% of Ontrak shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Ontrak has a net margin of -261.48% compared to Ontrak's net margin of -9,873.97%. Ontrak's return on equity of -114.84% beat BioRestorative Therapies' return on equity.
Summary
BioRestorative Therapies beats Ontrak on 10 of the 16 factors compared between the two stocks.
Get Ontrak News Delivered to You Automatically
Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools